ALEXANDRA REIVITIS: Open Payments
NPI 1407528771 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $119 |
| Lilly USA, LLC | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: Yeztugo, GEMTESA, MOUNJARO, SHINGRIX, KISUNLA, AMVUTTRA, BREZTRI.
Industry payments across CA — which companies pay providers there.
